Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Phytochemistry ; 88: 67-73, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23351982

ABSTRACT

Lawsonia inermis (Lythraceae) known as henna is one of the most popular and ancient plants used in cosmetics and hair dying. It is cultivated for its leaves but other parts such as seeds, flowers, stem bark and roots are also used in traditional medicine for millennia. Henna tattoo paste also proved to be beneficial for wound healing and in several skin diseases suggesting potent anti-inflammatory activity. To evaluate henna anti-inflammatory activity, 31 compounds, including three 1,5-diphenylpent-3-en-1-yne derivatives, lawsochylin A-C and three methyl naphthalene carboxylates, lawsonaphthoate A-C, were isolated from the stems and leaves of henna utilizing a bioassay-guided fractionation. The structures of the compounds were elucidated by spectroscopic data. Two compounds, lawsochylin A and lawsonaphthoate A showed potent anti-inflammatory activity by inhibition of superoxide anion generation (IC(50)=1.80 and 1.90 µg/ml) and elastase release (IC(50)=1.58 and 3.17 µg/ml) of human neutrophils in response to fMLP or cytochalasin B. Moreover, the known compounds, luteolin, apigenin, 4S-4-hydroxy-α-tetralone, and 2-butoxysuccinic acid, also showed potent inhibition of superoxide anion generation (IC(50)=0.75-1.78 µg/ml) and elastase release (IC(50)=1.62-3.61 µg/ml).


Subject(s)
Anti-Inflammatory Agents/chemistry , Anti-Inflammatory Agents/pharmacology , Carboxylic Acids/chemistry , Carboxylic Acids/pharmacology , Lawsonia Plant/chemistry , Neutrophils/drug effects , Carboxylic Acids/classification , Humans , Inhibitory Concentration 50 , Magnetic Resonance Spectroscopy , Molecular Structure , Naphthalenes/chemistry , Naphthalenes/classification , Naphthalenes/pharmacology , Plant Leaves/chemistry , Plant Stems/chemistry
2.
Int J Drug Policy ; 22(4): 274-7, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21482092

ABSTRACT

BACKGROUND: Spice is the iconic brand name of a smokeable herbal mixture containing synthetic cannabinoid receptor agonists. It has been available on the Internet/in head shops in Europe since at least 2006. The synthetic cannabinoid receptor agonist constituents of Spice were classified in the UK as Class B agents in December 2009. This study assessed the impact of this legislation on the synthetic cannabinoid receptor agonists present in Spice products and whether new synthetic cannabinoid receptor agonists outside of the legislation are now available. METHODS: Spice products were bought, prior to and after the change in the UK legislation, from a range of Internet legal high websites selling to UK consumers. Products were analysed using liquid chromatography high-resolution tandem mass spectrometry (LCMSMS). Identification of the synthetic cannabinoid receptor agonist(s) detected was made by comparison to existing databases or by 'in silico' methods. RESULTS: Sixteen products were purchased prior to the UK control of synthetic cannabinoid receptor agonists; all contained at least one synthetic cannabinoid receptor agonist. 20 products were purchased after the UK control; no active compounds were detected in 3 (15%). The remaining 17 (85%) all contained at least one classified synthetic cannabinoid receptor agonist. Additionally, 2 synthetic cannabinoid receptor agonists not covered under current UK generic legislation (AM-694 and the 'novel Belarus compound') were detected. CONCLUSION: Despite the UK 'Spice' classification, classified synthetic cannabinoid receptor agonists continue to be supplied over the Internet to UK users. Furthermore, new synthetic cannabinoid receptor agonists not covered by the legislation are appearing. Consideration needs to be given to reviewing the UK legislation so that suppliers cannot circumvent it by supplying legal alternatives to the classified synthetic cannabinoid receptor agonists.


Subject(s)
Cannabinoid Receptor Agonists , Cannabinoids/classification , Drug and Narcotic Control/legislation & jurisprudence , Illicit Drugs/classification , Illicit Drugs/legislation & jurisprudence , Cannabinoids/analysis , Cannabinoids/chemistry , Cannabinoids/economics , Chromatography, High Pressure Liquid , Crime/legislation & jurisprudence , Humans , Illicit Drugs/chemistry , Illicit Drugs/economics , Indoles/analysis , Indoles/classification , Inhalation Exposure , Internet/economics , Naphthalenes/analysis , Naphthalenes/classification , Smoke , Tandem Mass Spectrometry , United Kingdom
3.
Regul Toxicol Pharmacol ; 51(2 Suppl): S6-14, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18364246

ABSTRACT

This report provides a summary of deliberations conducted under the charge for members of Module A participating in the Naphthalene State-of-the-Science Symposium (NS3), Monterey, CA, October 9-12, 2006. Whole animal bioassays have been performed by the National Toxicology Program in mice and rats to ascertain the carcinogenic potential of naphthalene by inhalation exposure. A statistically significant increased incidence of pulmonary alveolar/bronchiolar adenoma (a benign lesion), was observed among female mice; an observed increase among the males did not reach statistical significance. No nasal tumors were observed in either sex. A tumorigenic response was observed in both sexes of rats, in males an increased incidence of nasal respiratory epithelium adenoma (a benign rather than malignant lesion) and in females, olfactory epithelial neuroblastoma. Interpretations of these studies vary. On the one hand, evidence of extensive non-neoplastic response in both sexes of both species indicates cytotoxicity occurred at all doses, and strongly suggests that cytotoxicity played a significant role in the tumor responses observed in the target tissues. On the other hand, olfactory epithelial neuroblastoma has rarely been observed in NTP bioassays. This review seeks to develop a consensus understanding of the scientific evidence provided by these studies, taking into account that they have been used as the basis for quantitative human cancer risk assessment, and suggests scientific studies that, if performed, could resolve scientific uncertainties.


Subject(s)
Carcinogenicity Tests/methods , Carcinogens, Environmental/toxicity , Naphthalenes/toxicity , Adenoma/chemically induced , Adenoma/pathology , Administration, Inhalation , Animals , Bronchi/drug effects , Bronchi/pathology , Carcinogens, Environmental/administration & dosage , Carcinogens, Environmental/classification , Esthesioneuroblastoma, Olfactory/chemically induced , Esthesioneuroblastoma, Olfactory/pathology , Female , Inhalation Exposure , Lung Neoplasms/chemically induced , Lung Neoplasms/pathology , Male , Mice , Naphthalenes/administration & dosage , Naphthalenes/classification , Nasal Cavity/drug effects , Nasal Cavity/pathology , Nose Neoplasms/chemically induced , Nose Neoplasms/pathology , Olfactory Mucosa/drug effects , Olfactory Mucosa/pathology , Pulmonary Alveoli/drug effects , Pulmonary Alveoli/pathology , Rats
4.
Regul Toxicol Pharmacol ; 51(2 Suppl): S37-42, 2008 Jul.
Article in English | MEDLINE | ID: mdl-17980943

ABSTRACT

Studies demonstrating that naphthalene produces respiratory tract tumors in mice and rats raised the question of whether humans are at risk for cancer, at environmental or workplace concentrations of naphthalene. Arguments in favor of a threshold-dependent mode of action for tumor induction have been based on the facts that naphthalene does not appear to bind to DNA in vivo and that the rodent tumors occurred at high dose levels associated with substantial target site toxicity. A summary of more than 45 publications describing results for naphthalene in genetic toxicology test methods shows that 80% of the studies reported found no evidence of genotoxicity for naphthalene and that some of the studies which reported positive finding were technically unsuited to study this class of chemicals and, therefore, generated unreliable data. The remaining positive findings for naphthalene were all consistent with secondary DNA effects produced by toxicity from naphthalene alone or one of its metabolites. Based on the data reviewed in this report, it is not apparent that genetic lesions produced by naphthalene or any of its metabolites drive the tumorigenic activity.


Subject(s)
Air Pollutants/toxicity , Carcinogens, Environmental/toxicity , Mutagens/toxicity , Naphthalenes/toxicity , Air Pollutants/classification , Air Pollutants/metabolism , Animals , Carcinogens, Environmental/classification , Carcinogens, Environmental/metabolism , Chromosome Breakage , DNA/drug effects , DNA Damage , Dose-Response Relationship, Drug , Mice , Mutagenicity Tests , Mutagens/classification , Naphthalenes/classification , Naphthalenes/metabolism , Rats , Risk Assessment
5.
Magn Reson Chem ; 44(1): 30-4, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16259050

ABSTRACT

In the course of the basic hydrolysis of four eremophilane esters isolated from Robinsonecio gerberifolius, some rearrangements, eliminations, and additions occurred. Five compounds were obtained, three of them not previously described. Additionally, a new sesquiterpene was produced by autooxidation of compound 1. The (1)H and (13)C NMR spectra of these compounds were completely assigned by utilization of HMQC, HMBC, COSY, DEPT, and NOESY techniques. The long-range coupling constants of the peroxide 10 are reported, and all its coupling constants (2)J(H, H), (3)J(H, H), and (4)J(H, H) are calculated at the B3LYP/6-31G(d,p) level of theory. Their magnitude is explained in terms of electronic delocalization and the additivity of stereoelectronic effects.


Subject(s)
Asteraceae/chemistry , Esters/chemistry , Naphthalenes/chemistry , Magnetic Resonance Spectroscopy , Molecular Structure , Naphthalenes/classification , Polycyclic Sesquiterpenes , Sesquiterpenes
SELECTION OF CITATIONS
SEARCH DETAIL
...